RGLS stock surges after Phase 1 data for kidney disease candidate (NASDAQ:RGLS)
The shares of clinical-stage biotech Regulus Therapeutics Inc
Source: seekingalpha.com
Page 6 - Multiple Ascending Dose News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Multiple Ascending Dose. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Multiple Ascending Dose Today - Breaking & Trending Today
Regulus Therapeutics Announces Positive Topline Safety and Pharmacokinetic (PK) Data from the Phase 1 Single-Ascending Dose (SAD) Clinical Trial of RGLS8429 for the treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Phase 1b Multiple Ascending Dose Study Initiated RGLS8429 in healthy volunteers was well-tolerated with dose-proportional PK Topline data from first cohort of patients with ADPKD anticipated in 1H... | September 12, 2022
Source: marketscreener.com
Moleculin Reports Second Quarter 2022 Financial Results and Provides Programs Update
/PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug...
Source: prnewswire.com
Saniona AB: Saniona publishes its interim report for the first quarter of 2022
Q1 2022 (Q1 2021) Revenue was SEK 6.6 M (3.4 M)Operating loss was SEK -133.2 M (-94.1 M)Net loss was SEK -133.4 M (-83.4 M)Loss per share was SEK -2.14 (-1.34)Diluted loss per share was SEK
Source: finanznachrichten.de
Aptorum Group Limited Reports 2021 Fiscal Year End Financial Results and Provides Business Update
Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group" or "We"), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology
Source: finanznachrichten.de